SEC Form DFiling only, no announcement found
OS Therapies, based in Grasonville, MD, reported $5,000,000 sold in a private offering of equity and debt and options or warrants, with the first sale on August 10, 2026, in a Form D filed with the SEC on August 25, 2026. The filing says 10 investors have already invested. The offering authorizes up to $10,000,000.
Legal name on the filing: OS Therapies Inc.
| Amount sold | $5,000,000Basis: Form D total amount sold, as of the filing of August 25, 2026. Not the announced round size. |
|---|---|
| Total offering | $10,000,000The most the company may sell under this offering. Not money raised. |
| Remaining to be sold | $5,000,000 |
| Securities offered | Equity; Debt; Option, warrant or other right to acquire another security; Security to be acquired upon exercise of option, warrant or other right |
| Exemption claimed | Rule 506(b) |
| Date of first sale | August 10, 2026 |
| Investors already invested | 10 |
| Non-accredited investors | None |
| Minimum investment accepted | $0 |
| Part of a merger or acquisition | No |
| Industry group | Biotechnology |
| Principal place of business | Grasonville, MD |
| Jurisdiction of incorporation | DELAWARE |
| Entity type | Corporation |
| Year of incorporation | over five years ago |
| Revenue range | Decline to Disclose |
| SEC CIK | 1795091 |
Round name, valuation, lead investor and participants are not on a Form D, so they are not shown. They appear here only when a press or company announcement is matched to this deal.
| Name, as filed | Relationship | VC Beast profile |
|---|---|---|
| Paul A. Romness | Executive Officer, DirectorChairman, President and Chief Executive Officer | None linked |
| Robert G. Petit | Executive OfficerChief Medical Officer and Chief Scientific Officer | None linked |
| Christopher P. Acevedo | Executive OfficerChief Financial Officer | None linked |
| John Ciccio | Director | None linked |
| Avril McKean Dieser | Director | None linked |
| Craig Eagle | Director | None linked |
| Olivier Jarry | Director | None linked |
| Theodore F. Search | Director | None linked |
Form D lists the company's executive officers, directors and promoters. A director is often an investor's board representative, but the filing does not say who invested.
| Filed | Form | Amount sold | Total offering |
|---|---|---|---|
| Aug 25, 2026 | D (original) | $5,000,000 | $10,000,000 |
The latest filing states the current amount sold; an amendment replaces the figure before it.
From the issuer's EDGAR filing history. Amounts are shown for filings in our warehouse, which holds operating-company filings from July 16, 2026.
Filing only, no announcement found. The only source for this deal is the company's own SEC filing, made under penalty of law. When a press or company announcement is matched to it, it is cited here with the round name it gives.
Amount sold is the filing's total amount sold; total offering is its authorized maximum. This page was built from filings received through September 29, 2026. Report an error on the corrections page.
Cite this deal
VC Beast, "OS Therapies: SEC Form D deal record", https://vcbeast.com/deals/os-therapies-form-d-2026-08-10. Source: SEC EDGAR, accession 0000921895-26-002306.